Seroatlas · Human Serome Atlas

GPR153

Probable G-protein coupled receptor 153

Also known as: GP153_HUMAN, PGR1

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6NV75
Gene
GPR153
Ensembl
ENSG00000158292
Chromosome
1
Canonical length
609 aa
Protein class
G-protein coupled receptors, Predicted membrane proteins

OverviewNCBI Gene

This gene encodes an integral membrane protein that belongs to the Class A rhodopsin superfamily of G protein coupled receptors. The encoded protein is expressed primarily in the central nervous system. A knockdown of the orthologous gene in rat is associated with a significant reduction in food intake and impaired decision making ability. Mutations in this gene are associated with schizophrenia, autism, and other neuropsychiatric disorders. The expression of this gene is activated by the glioma-associated oncogene homolog 1 transcription factor which, in turn, is activated by sonic hedgehog in normal and tumorigenic cells. [provided by RefSeq, Feb 2017]

Canonical amino-acid sequenceUniProt

609 residues, UniProt reviewed canonical sequence.

>Q6NV75|GPR153
     1  MSDERRLPGS AVGWLVCGGL SLLANAWGIL SVGAKQKKWK PLEFLLCTLA ATHMLNVAVP
    61  IATYSVVQLR RQRPDFEWNE GLCKVFVSTF YTLTLATCFS VTSLSYHRMW MVCWPVNYRL
   121  SNAKKQAVHT VMGIWMVSFI LSALPAVGWH DTSERFYTHG CRFIVAEIGL GFGVCFLLLV
   181  GGSVAMGVIC TAIALFQTLA VQVGRQADRR AFTVPTIVVE DAQGKRRSSI DGSEPAKTSL
   241  QTTGLVTTIV FIYDCLMGFP VLVVSFSSLR ADASAPWMAL CVLWCSVAQA LLLPVFLWAC
   301  DRYRADLKAV REKCMALMAN DEESDDETSL EGGISPDLVL ERSLDYGYGG DFVALDRMAK
   361  YEISALEGGL PQLYPLRPLQ EDKMQYLQVP PTRRFSHDDA DVWAAVPLPA FLPRWGSGED
   421  LAALAHLVLP AGPERRRASL LAFAEDAPPS RARRRSAESL LSLRPSALDS GPRGARDSPP
   481  GSPRRRPGPG PRSASASLLP DAFALTAFEC EPQALRRPPG PFPAAPAAPD GADPGEAPTP
   541  PSSAQRSPGP RPSAHSHAGS LRPGLSASWG EPGGLRAAGG GGSTSSFLSS PSESSGYATL
   601  HSDSLGSAS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GPR153 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
7
Mean surface accessibility (rSASA)
0.49
Highest tissue expression
20 nTPM

Expression across tissuesHPA

Tissue

  • small intestine: 20 nTPM
  • amygdala: 13 nTPM
  • adipose tissue: 12 nTPM
  • cervix: 12 nTPM
  • pituitary gland: 11 nTPM
  • epididymis: 11 nTPM

Single-cell type

  • goblet cells: 110 nCPM
  • retinal horizontal cells: 58 nCPM
  • ocular epithelial cells: 54 nCPM
  • retinal amacrine cells: 53 nCPM
  • hepatocytes: 45 nCPM
  • lactotrophs: 35 nCPM

Immune cell

  • basophil: 0.3 nTPM
  • gdT-cell: 0.2 nTPM
  • naive CD8 T-cell: 0.2 nTPM
  • eosinophil: 0.1 nTPM
  • non-classical monocyte: 0.1 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • thalamus: 63 nTPM
  • amygdala: 41 nTPM
  • midbrain: 28 nTPM
  • cerebral cortex: 26 nTPM
  • hypothalamus: 23 nTPM
  • hippocampal formation: 19 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GPR153.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 149 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.29
gnomAD pLI
0
gnomAD missense Z
0.67
DepMap mean gene effect
-0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GPR153 as an antibody target. Whether an autoantibody or antibody against GPR153 could matter depends on whether native GPR153 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GPR153 is annotated at the cell surface, where native GPR153 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GPR153 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GPR153. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...